GlassScriptPhysician profile
Dia A Abochamh
NPI 1417952029
$61,974.26
in general payments reported to CMS, 2019-2025
32 companies · $17K in 2025
The $17K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,005 · 2020: $845 · 2021: $1,137 · 2022: $10K · 2023: $16K · 2024: $16K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $45K · Food and Beverage: $2,805 · Travel and Lodging: $1,028 · Education: $29.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $45,000.00 |
| Food and Beverage | $2,804.51 |
| Travel and Lodging | $1,028.46 |
| Education | $29.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $54,215.26 | 2022-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $2,061.81 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Compia Mri Quad Crt-D Surescan |
| Abbott Laboratories | $1,303.62 | 2019-2025 | Aveir, Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Boston Scientific Corporation | $1,037.44 | 2019-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor, Accolade Sr |
| Medtronic Vascular, INC. | $650.59 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $375.33 | 2021-2025 | Verquvo, Winrevair |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $258.56 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $242.85 | 2021-2025 | Eliquis, Camzyos |
| Amgen INC. | $207.59 | 2019-2024 | Repatha |
| Cardiovascular Systems INC. | $186.57 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $143.19 | 2023-2025 | |
| Shockwave Medical, INC | $133.93 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $131.14 | 2020 | |
| Janssen Pharmaceuticals, INC | $120.25 | 2020-2024 | Xarelto |
| Pfizer INC. | $108.92 | 2021-2024 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $89.81 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.67 | 2019-2023 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $78.62 | 2023-2024 | Uptravi, Opsumit |
| Stryker Corporation | $76.09 | 2023-2025 | Clottriever Bold Catheter, Spy-Phi System |
| Penumbra, INC. | $72.11 | 2025 | Indigo System |
| Esperion Therapeutics, INC. | $61.67 | 2021-2022 | |
| Lexicon Pharmaceuticals, INC. | $61.04 | 2023 | Inpefa |
| Scpharmaceuticals INC. | $51.75 | 2023-2025 | |
| Kestra Medical Technology Services, INC. | $39.81 | 2025 | Assure Wcd |
| Biotronik INC. | $37.86 | 2019 | |
| Sanofi-Aventis U.S. LLC | $36.06 | 2019-2023 | |
| Akcea Therapeutics, INC. | $25.51 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $23.39 | 2019 | |
| Cordis US Corp. | $19.00 | 2024 | Mynxgrip |
| Cook Medical LLC | $17.80 | 2021 | |
| Novo Nordisk INC | $14.75 | 2024 | Ozempic |
| Siemens Medical Solutions USA, INC. | $11.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dia Abochamh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.